Based on this observation, a new oncolytic adenovirus type 5 was recombined by replacing its promoter with E2F-1 promoter and inserting IL-15, an immune regulatory factor; IL-15 is a cytokine that regulates adaptive immune response and inhibits the proliferation of breast cancer cells via various immune cells [64, 65]. Here, E2F1 is linked to breast carcinoma.